组织芯片，组织微阵列

BCN962c	多器官肿瘤及癌旁或边缘组织组合芯片，附病理分级，TNM和临床分期，67例/96点，替代BCN962b
点数	96	例数	67
行数	8	列数	12
点直径(mm)	1.0	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:	Pla -Placenta Tes -Testis Pan -Pancreas Ski -Skin Ton -Tongue Lym -Lymph node Bla -Bladder Ova -Ovary Cer -Cervix Bre -Breast Kin -Kindey Lun -Lung Liv -Liver Pro -Prostate Col -Colon Sto -Stomach Eso -Esophagus
	AT () Malignant () Malignant (0.0) Malignant (I) Malignant (IA) Malignant (IB) Malignant (IB1) Malignant (II) Malignant (IIA) Malignant (IIB) Malignant (IIC) Malignant (III) Malignant (IIIA) Malignant (IIIC) NAT () Normal ()

TISSUE ARRAYS BCN962c

ESO

STO

COL

PRO

ESO

STO

COL

PRO

LIV

LUN

KIN

BRE

LIV

LUN

KIN

BRE

CER

OVA

BLA

LYM

CER

OVA

BLA

LYM

SKI

PAN

TES

TON

SKI

PAN

TES

PLA

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	Tumor Size	isBackUp
A1	1	58	F	Esophagus	Squamous cell carcinoma	1	T1bN0M0	I	Malignant	220.8	N
A2	2	67	M	Esophagus	Squamous cell carcinoma	1	T3N0M0	II	Malignant	*	N
A3	3	70	M	Esophagus	Squamous cell carcinoma	3	T3N1M0	III	Malignant	*	N
A4	4	66	M	Stomach	Adenocarcinoma	3	T3N2M0	III	Malignant	*	N
A5	5	53	M	Stomach	Adenocarcinoma	3	T3N2M0	III	Malignant	*	N
A6	6	34	F	Stomach	Adenocarcinoma	3	T3N0M0	IIB	Malignant	*	N
A7	7	70	F	Colon	Adenocarcinoma (sparse)	2	T3N0M0	IIA	Malignant	*	N
A8	8	37	M	Colon	Adenocarcinoma	2	T3N0M0	IIA	Malignant	5.03.50.5	N
A9	9	44	F	Colon	Mucinous adenocarcinoma	3	T3N0M0	IIA	Malignant	*	N
A10	10	56	M	Prostate	Adenocarcinoma (Gleason grade: 4, Gleason score: 4+4)	3	T3N0M0	III	Malignant	3*2.5	N
A11	11	64	M	Prostate	Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5)	3	T2N0M0	II	Malignant	875	N
A12	12	64	M	Prostate	Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5)	3	T2bN0M0	II	Malignant	764	N
B1	13	58	F	Esophagus	Adjacent normal esophagus tissue of No.1	*	*	*	NAT	*	N
B2	14	67	M	Esophagus	Adjacent normal esophagus tissue of No.2	*	*	*	NAT	*	N
B3	15	70	M	Esophagus	Adjacent normal esophagus tissue of No.3	*	*	*	NAT	*	N
B4	16	66	M	Stomach	Adjacent normal stomach tissue of No.4	*	*	*	NAT	*	N
B5	17	53	M	Stomach	Cancer adjacent stomach tissue of No.5	*	*	*	AT	*	N
B6	18	34	F	Stomach	Adjacent normal stomach tissue of No.6	*	*	*	NAT	*	N
B7	19	71	M	Colon	Adjacent normal colon tissue of No.7	*	*	*	NAT	*	N
B8	20	37	M	Colon	Adjacent normal colon tissue of No.8	*	*	*	NAT	*	N
B9	21	44	F	Colon	Cancer adjacent colon tissue of No.9	*	*	*	AT	*	N
B10	22	66	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	*	N
B11	23	71	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	*	N
B12	24	64	M	Prostate	Cancer adjacent prostate tissue	*	*	*	AT	*	N
C1	25	48	F	Liver	Hepatocellular carcinoma	2	T3N0M0	IIIA	Malignant	432	N
C2	26	52	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	6.04.54.5	N
C3	27	43	F	Liver	Hepatocellular carcinoma	3	T2N0M0	II	Malignant	432	N
C4	28	59	M	Lung	Invasive adenocarcinoma	*	T2aN0M0	IB	Malignant	*	N
C5	29	70	M	Lung	Squamous cell carcinoma	2	T3N0M0	IIB	Malignant	544	N
C6	30	62	M	Lung	Squamous cell carcinoma	3	T2aN1M0	IIB	Malignant	554	N
C7	31	72	F	Kindey	Clear cell carcinoma	1	T1bN0M0	I	Malignant	53.53	N
C8	32	57	M	Kindey	Clear cell carcinoma	1	T1bN0M0	I	Malignant	5.04.53.0	N
C9	33	45	F	Kindey	Clear cell carcinoma	1	T1N0M0	I	Malignant	544	N
C10	34	53	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	N
C11	35	49	F	Breast	Invasive carcinoma of no special type	2	*	*	Malignant	*	N
C12	36	29	F	Breast	Invasive carcinoma of no special type (breast tissue)	*	T2N0M0	IIA	Malignant	*	N
D1	37	48	F	Liver	Cancer adjacent liver tissue of No.25	*	*	*	AT	*	N
D2	38	52	F	Liver	Adjacent normal liver tissue of No.26	*	*	*	NAT	*	N
D3	39	43	F	Liver	Cancer adjacent liver tissue of No.27	*	*	*	AT	*	N
D4	40	59	M	Lung	Cancer adjacent lung tissue of No.28	*	*	*	AT	*	N
D5	41	70	M	Lung	Adjacent normal lung tissue of No.29	*	*	*	NAT	*	N
D6	42	62	M	Lung	Adjacent normal lung tissue of No.30	*	*	*	NAT	*	N
D7	43	72	F	Kindey	Adjacent normal kindey tissue of No.31	*	*	*	NAT	*	N
D8	44	57	M	Kindey	Adjacent normal kindey tissue of No.32	*	*	*	NAT	*	N
D9	45	45	F	Kindey	Cancer adjacent kindey tissue of No.33	*	*	*	AT	*	N
D10	46	53	F	Breast	Adjacent normal breast tissue of No.34 (fibrous and adipose tissue)	*	*	*	NAT	*	N
D11	47	49	F	Breast	Adjacent normal breast tissue of No.35	*	*	*	NAT	*	N
D12	48	29	F	Breast	Adjacent normal breast tissue of No.36	*	*	*	NAT	*	N
E1	49	71	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant	3.52.51.0	N
E2	50	58	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant	*	N
E3	51	42	F	Cervix	Squamous cell carcinoma (sparse)	3	*	*	Malignant	*	N
E4	52	58	F	Ovary	High grade serous carcinoma	*	T3cN0M0	IIIC	Malignant	*	N
E5	53	37	F	Ovary	High grade serous carcinoma	*	T1aN0M0	IA	Malignant	6.54.53.0	N
E6	54	67	F	Ovary	High grade serous carcinoma	*	T1N0M0	I	Malignant	13126	N
E7	55	79	F	Bladder	Low grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5	N
E8	56	54	F	Bladder	Low grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*	N
E9	57	72	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*	N
E10	58	39	M	Lymph node	Diffuse B-cell lymphoma of right armpit	*	*	*	Malignant	*	N
E11	59	40	M	Lymph node	Diffuse B-cell lymphoma of left neck	*	*	*	Malignant	*	N
E12	60	51	M	Lymph node	Diffuse B-cell lymphoma of right thigh	*	*	*	Malignant	742	N
F1	61	45	F	Cervix	Adjacent normal cervical tissue	*	*	*	NAT	*	N
F2	62	58	F	Cervix	Cancer adjacent cervical tissue of No.50	*	*	*	AT	*	N
F3	63	27	F	Cervix	Adjacent normal cervical tissue	*	*	*	NAT	*	N
F4	64	64	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	*	N
F5	65	47	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	*	N
F6	66	29	F	Ovary	Adjacent normal ovary tissue	*	*	*	NAT	*	N
F7	67	79	F	Bladder	Adjacent normal bladder tissue of No.55	*	*	*	NAT	*	N
F8	68	54	F	Bladder	Adjacent normal bladder tissue of No.56	*	*	*	NAT	*	N
F9	69	72	F	Bladder	Cancer adjacent bladder tissue of No.57	*	*	*	AT	*	N
F10	70	32	M	Lymph node	Adjacent normal lymph node tissue	*	*	*	NAT	*	N
F11	71	35	M	Lymph node	Adjacent normal lymph node tissue	*	*	*	NAT	*	N
F12	72	34	M	Lymph node	Adjacent normal lymph node tissue	*	*	*	NAT	*	N
G1	73	69	M	Skin	Squamous cell carcinoma of right shin	2	T2N0M0	II	Malignant	6.561.2	N
G2	74	78	M	Skin	Squamous cell carcinoma	2	T2N1M0	III	Malignant	*	N
G3	75	79	M	Skin	Squamous cell carcinoma of left thigh (sparse)	*	TisN0M0	0.0	Malignant	3*2	N
G4	76	58	F	Pancreas	Adenocarcinoma (sparse)	1	T3N1M0	IIB	Malignant	*	N
G5	77	55	M	Pancreas	Adenocarcinoma	2	T3N0M0	IIA	Malignant	*	N
G6	78	53	M	Pancreas	Duct adenocarcinoma	2	T3N0M0	IIA	Malignant	*	N
G7	79	50	M	Testis	Anaplastic seminoma	*	T1N0M0	I	Malignant	*	N
G8	80	55	M	Testis	Seminoma	*	T1N0M0	I	Malignant	*	N
G9	81	55	M	Testis	Embryonal carcinoma	*	T1N0M0	I	Malignant	*	N
G10	82	22	M	Testis	Embryonal carcinoma	*	T1N0M0	I	Malignant	*	N
G11	83	1	M	Testis	Embryonic rhabdomyosarcoma	*	T1bN0M0	IIA	Malignant	*	N
G12	84	18	M	Tongue	Embryonic rhabdomyosarcoma	*	T1bN0M0 G3	IIC	Malignant	*	N
H1	85	62	M	Skin	Cancer adjacent skin tissue	*	*	*	AT	*	N
H2	86	78	M	Skin	Cancer adjacent skin tissue of No.74	*	*	*	AT	*	N
H3	87	79	M	Skin	Cancer adjacent skin tissue of No.75	*	*	*	AT	*	N
H4	88	42	M	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	*	N
H5	89	55	F	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	*	N
H6	90	51	M	Pancreas	Adjacent normal pancreas tissue	*	*	*	NAT	*	N
H7	91	50	M	Testis	Adjacent normal testis tissue of No.79	*	*	*	NAT	*	N
H8	92	55	M	Testis	Adjacent normal testis tissue of No.80	*	*	*	NAT	*	N
H9	93	41	M	Testis	Adjacent normal testis tissue	*	*	*	NAT	*	N
H10	94	45	M	Testis	Adjacent normal testis tissue	*	*	*	NAT	*	N
H11	95	4 Mon	F	Placenta	Placenta tissue	*	*	*	Normal	*	N
H12	96	4 Mon	M	Placenta	Placenta tissue	*	*	*	Normal	*	N
Tissue Marker